Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Managed Care & Specialty Pharmacy|April 12, 2021
Understanding the evolution of coverage policies for prophylaxis treatments of hemophilia A without inhibitors: a payer Delphi panelMarlon Graf, Rifat Tuly, Carolyn Harley, et al.Transplantation Proceedings|February 18, 2024
Gaining Consensus Around Patient Risk Groups and Prognostic Profiles to Guide CMV Management Among Patients With Allogeneic Hematopoietic Stem Cell Transplant: Insights From a Delphi Panel With Hematopoietic Stem Cell Transplant ExpertsMarlon Graf, Rifat Tuly, Priti Pednekar, et al.Clinical Transplantation|January 5, 2023
Gaining consensus around patient risk groups and prognostic profiles to guide CMV management among patients with solid organ transplant: Insights from a Delphi panel with SOT expertsPriti Pednekar, Marlon Graf, Rifat Tuly, et al.Journal of Blood Medicine|October 28, 2021
A Delphi Consensus Approach for Difficult-to-Treat Patients with Severe Hemophilia A without InhibitorsSreenivas P Veeranki, Priti Pednekar, Marlon Graf, et al.The International Journal of Neuroscience|May 26, 2020
Challenges and opportunities in insomnia disorderMeaghan Roach, Timothy Juday, Rifat Tuly, et al.Multiple Sclerosis and Related Disorders|October 10, 2024
Real-world persistence and adherence of ofatumumab versus oral and injectable disease-modifying therapies in patients with multiple sclerosisCarrie M Hersh, Magdaliz Gorritz, Chi-Chang Chen, et al.Current Medical Research and Opinion|October 29, 2025
Treatment sequencing patterns and healthcare resource utilization in patients with Crohn's disease initiating biologics: a 3-year retrospective claims-based analysisMagdaliz Gorritz, Navneet Upadhyay, Rifat Tuly, et al.Clinical and Translational Gastroenterology|November 21, 2025
Geographic Distribution of Gastroenterologists and Patients With Inflammatory Bowel Disease in the United StatesNavneet Upadhyay, Aisha Vadhariya, Magdaliz Gorritz, et al.Antimicrobial Resistance and Infection Control|June 14, 2022
Economic burden of antibiotic-not-susceptible isolates in uncomplicated urinary tract infection: Analysis of a US integrated delivery network databaseJason Shafrin, Alen Marijam, Ashish V Joshi, et al.Antimicrobial Resistance and Infection Control|November 5, 2022
Impact of suboptimal or inappropriate treatment on healthcare resource use and cost among patients with uncomplicated urinary tract infection: an analysis of integrated delivery network electronic health recordsJason Shafrin, Alen Marijam, Ashish V Joshi, et al.Pageof 2